Hudock, Inc. Biogen Inc. Transaction History

Hudock, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$187.54 - $223.02 $5,626 - $6,690	-30 Reduced 20.27%	118 $24,000
Q1 2022 May 02, 2022	BUY	$193.77 - $244.14 $193 - $244	1 Added 0.68%	148 $31,000
Q4 2021 Jan 19, 2022	BUY	$223.92 - $287.77 $447 - $575	2 Added 1.38%	147 $35,000
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $1,414 - $1,845	-5 Reduced 3.33%	145 $41,000
Q2 2021 Aug 09, 2021	BUY	$259.0 - $414.71 $2,590 - $4,147	10 Added 7.14%	150 $51,000
Q4 2020 Feb 05, 2021	BUY	$236.26 - $355.63 $9,450 - $14,225	40 Added 40.0%	140 $34,000
Q1 2019 Apr 23, 2019	SELL	$216.71 - $338.96 $3,033 - $4,745	-14 Reduced 12.28%	100 $23,000
Q4 2017 Jan 30, 2018	BUY	$307.64 - $344.58 $1,230 - $1,378	4 Added 3.64%	114 $36,000
Q3 2017 Oct 27, 2017	BUY	$281.15 - $329.69 $2,811 - $3,296	10 Added 10.0%	110 $34,000
Q2 2017 Aug 08, 2017	BUY	N/A	100	100 $27,000

993

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.